Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence Journal Article


Authors: Rao, V.; Gao, F.; Chen, B.; Jacobs, W. R. Jr; Glickman, M. S.
Article Title: Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence
Abstract: Recent studies have shown that fine structural modifications of Mycobacterium tuberculosis cell envelope lipids mediate host cell immune activation during infection. One such alteration in lipid structure is cis-cyclopropane modification of the mycolic acids on trehalose dimycolate (TDM) mediated by proximal cyclopropane synthase of α mycolates (pcaA), a proinflammatory lipid modification during early infection. Here we examine the pathogenetic role and immunomodulatory function of mycolic acid cyclopropane stereochemistry by characterizing an M. tuberculosis cyclopropane-mycolic acid synthase 2 (cmaA2) null mutant (ΔcmaA2) that lacks trans-cyclopropanation of mycolic acids. Although titers of WT and ΔcmaA2 organisms were identical during mouse infection, ΔcmaA2 bacteria were hypervirulent while inducing larger granulomas than WT M. tuberculosis. The hypervirulence of the ΔcmaA2 strain depended on host TNF-α and IFN-γ. Loss of trans-cyclopropanation enhanced M. tuberculosis -induced macrophage inflammatory responses, a phenotype that was transferable with petroleum ether extractable lipids. Finally, purified TDM lacking trans-cyclopropane rings was 5-fold more potent in stimulating macrophages. These results establish cmaA2-dependent trans-cyclopropanation of TDM as a suppressor of M. tuberculosis-induced inflammation and virulence. In addition, cyclopropane stereochemistries on mycolic acids interact directly with host cells to both positively and negatively influence host innate immune activation.
Keywords: controlled study; survival rate; unclassified drug; pathogenesis; nonhuman; animal cell; mouse; phenotype; animals; mice; animal tissue; cells, cultured; infection; animal experiment; animal model; inflammation; mice, scid; bacterial virulence; mice, inbred balb c; mice, inbred c57bl; mycolic acid; mycobacterium tuberculosis; bacterial proteins; cyclopropanes; methyltransferases; mycolic acids; tumor necrosis factor alpha; tumor necrosis factor-alpha; gamma interferon; lung; innate immunity; immunomodulation; macrophage; macrophages; host cell; tuberculosis; stereochemistry; granuloma; enzyme; cyclopropanation; membrane lipids; interferon type ii; cord factor; cyclopropane; mycolic acid synthase; petroleum ether; cord factors
Journal Title: Journal of Clinical Investigation
Volume: 116
Issue: 6
ISSN: 0021-9738
Publisher: American Society for Clinical Investigation  
Date Published: 2006-06-01
Start Page: 1660
End Page: 1667
Language: English
DOI: 10.1172/jci27335
PUBMED: 16741578
PROVIDER: scopus
PMCID: PMC1464906
DOI/URL:
Notes: --- - "Cited By (since 1996): 63" - "Export Date: 4 June 2012" - "CODEN: JCINA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vivek K Rao
    3 Rao
  2. Michael Glickman
    109 Glickman
  3. Feng Gao
    3 Gao